1. Home
  2. MIST vs ELTK Comparison

MIST vs ELTK Comparison

Compare MIST & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ELTK
  • Stock Information
  • Founded
  • MIST 2003
  • ELTK 1970
  • Country
  • MIST Canada
  • ELTK Israel
  • Employees
  • MIST N/A
  • ELTK N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ELTK Electrical Products
  • Sector
  • MIST Health Care
  • ELTK Technology
  • Exchange
  • MIST Nasdaq
  • ELTK Nasdaq
  • Market Cap
  • MIST 77.8M
  • ELTK 73.5M
  • IPO Year
  • MIST N/A
  • ELTK 1997
  • Fundamental
  • Price
  • MIST $1.52
  • ELTK $10.74
  • Analyst Decision
  • MIST Strong Buy
  • ELTK
  • Analyst Count
  • MIST 3
  • ELTK 0
  • Target Price
  • MIST $13.00
  • ELTK N/A
  • AVG Volume (30 Days)
  • MIST 149.8K
  • ELTK 21.1K
  • Earning Date
  • MIST 11-11-2024
  • ELTK 08-15-2024
  • Dividend Yield
  • MIST N/A
  • ELTK 2.02%
  • EPS Growth
  • MIST N/A
  • ELTK 19.67
  • EPS
  • MIST N/A
  • ELTK 0.95
  • Revenue
  • MIST N/A
  • ELTK $46,431,000.00
  • Revenue This Year
  • MIST N/A
  • ELTK $5.41
  • Revenue Next Year
  • MIST N/A
  • ELTK $12.11
  • P/E Ratio
  • MIST N/A
  • ELTK $11.45
  • Revenue Growth
  • MIST N/A
  • ELTK 7.18
  • 52 Week Low
  • MIST $1.12
  • ELTK $8.04
  • 52 Week High
  • MIST $3.52
  • ELTK $22.80
  • Technical
  • Relative Strength Index (RSI)
  • MIST 59.56
  • ELTK 59.02
  • Support Level
  • MIST $1.43
  • ELTK $10.74
  • Resistance Level
  • MIST $1.54
  • ELTK $10.97
  • Average True Range (ATR)
  • MIST 0.08
  • ELTK 0.24
  • MACD
  • MIST 0.01
  • ELTK 0.00
  • Stochastic Oscillator
  • MIST 84.21
  • ELTK 89.47

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

Share on Social Networks: